Novel intralesional nemolizumab for chronic scalp prurigo nodularis. [PDF]
Gaven E, Siddiqui S, Stout M.
europepmc +1 more source
Beyond Histamine: Mast Cell-Neuron Communication in Chronic Pruritic and Pain Disorders. [PDF]
Kagan T, Yosipovitch G.
europepmc +1 more source
Clinical Outcomes of Abrocitinib in Prurigo Spectrum Disorders: A Case Series. [PDF]
Chakravadhanula U, Nagarajan M, Bhat S.
europepmc +1 more source
Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient. [PDF]
Valenzuela Godoy D +2 more
europepmc +1 more source
Cutaneous B-cell lymphoid hyperplasia successfully treated with oral abrocitinib: A case report. [PDF]
Sparling K +3 more
europepmc +1 more source
Direct randomized evidence for systemic targeted therapies in prurigo nodularis: a systematic review and meta-analysis. [PDF]
Yu Y, Li S, Chen W, Chen X.
europepmc +1 more source
Targeting type 2 inflammation in dermatology: mechanisms and clinical implications. [PDF]
Khalil N, Farhadi L, Yosipovitch G.
europepmc +1 more source
Literature Review: Recent Therapeutic Advances in The Management of Prurigo Nodularis: From Conventional Therapy to Biologics and Targeted Small-Molecule Agents. [PDF]
Avriyanti E +6 more
europepmc +1 more source
Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report. [PDF]
Liao X, Lu Y.
europepmc +1 more source

